Farampator is primarily researched for its potential cognitive-enhancing effects, particularly in conditions involving memory and learning impairments. It has been studied in the context of Alzheimer's disease and other neurodegenerative disorders, where it may help improve cognitive function by modulating glutamate receptors in the brain. Additionally, Farampator has been explored for its potential use in addressing age-related cognitive decline and enhancing memory in healthy individuals. Its ability to influence synaptic plasticity makes it a candidate for further development in neuropharmacology. However, its application remains largely experimental, with ongoing research to determine its safety, efficacy, and therapeutic potential.